Follow this link: LAPIX Therapeutics Inc. Announces the Issuance of U.S. Patent for LPX-TI641, Its First-in-Class, Orally Administered Tim3/4 Agonist for Treg Expansion...
Follow this link: LAPIX Therapeutics Inc. Announces the Issuance of U.S. Patent for LPX-TI641, Its First-in-Class, Orally Administered Tim3/4 Agonist for Treg Expansion...
Read more: Umoja Biopharma Presents New Preclinical Data at the American Society of Gene and Cell Therapy 26th Annual Meeting Demonstrating Potent In Vivo CAR T...
Go here to see the original: Corvus Pharmaceuticals to Present New CPI-818 Data at the International Conference on Malignant Lymphoma
Continued here: Jonathan Milner Announces That He is Taking Steps to Call an Extraordinary General Meeting of Abcam Shareholders
More here: Biotech Entrepreneur and Venture Capitalist Dinesh Patel Discusses Therapeutics and Medical Devices with CancerVAX CEO Ryan Davies
See the rest here: Real-World Data from Over 6,100 Patients Corroborates Significant Pain Reduction from Prior Prospective Studies for Patients Treated with SPRINT® PNS
Link: AB Science summarizes key messages from its participation to a panel discussion at the 2023 ALS Drug Development Summit
Link: Women In Bio Announces Appointment of Gina Ford as Executive Director
Regenerative Medicine Market to Reach a Valuation of USD 127.86 ... Bloomberg
Tehran to host intl. congress on biomedicine, stem cells Tehran Times
Recent Comments